C-Type Natriuretic Peptide Prevents Heart Failure: Endothelium and Fibroblast Sources
Study reveals endothelium- and fibroblast-derived CNP (C-type natriuretic peptide) prevents cardiac remodeling and heart failure through local paracrine signaling.
Quick Facts
What This Study Found
Study reveals endothelium- and fibroblast-derived CNP (C-type natriuretic peptide) prevents cardiac remodeling and heart failure through local paracrine signaling.
Key Numbers
How They Did This
In publication.
Why This Research Matters
Relevant to peptide therapeutics.
The Bigger Picture
Advances peptide evidence.
What This Study Doesn't Tell Us
In publication.
Questions This Raises
- ?Long-term implications?
- ?Evidence comparison?
- ?Next steps?
Trust & Context
- Key Stat:
- Key finding Study reveals endothelium- and fibroblast-derived CNP (C-type natriuretic peptide) prevents cardiac
- Evidence Grade:
- Based on design.
- Study Age:
- Published in 2025.
- Original Title:
- Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.
- Published In:
- Arteriosclerosis, thrombosis, and vascular biology, 45(7), 1044-1063 (2025)
- Authors:
- Aubdool, Aisah A, Moyes, Amie J, Perez-Ternero, Cristina, Baliga, Reshma S, Sanghera, Jaspinder Singh, Syed, M Taaha, Jaigirdar, Kareemah, Panesar, Anmolpreet K, Tsui, Janice C, Li, Yanming, Vasquez, Hernan G, Shen, Ying H, LeMaire, Scott A, Raffort, Juliette, Mallat, Ziad, Lu, Hong S, Daugherty, Alan, Hobbs, Adrian J
- Database ID:
- RPEP-10013
Evidence Hierarchy
Frequently Asked Questions
What does this mean?
Study reveals endothelium- and fibroblast-derived CNP (C-type natriuretic peptide) prevents cardiac remodeling and heart failure through local paracrine signaling.
How reliable?
Consult publication.
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-10013APA
Aubdool, Aisah A; Moyes, Amie J; Perez-Ternero, Cristina; Baliga, Reshma S; Sanghera, Jaspinder Singh; Syed, M Taaha; Jaigirdar, Kareemah; Panesar, Anmolpreet K; Tsui, Janice C; Li, Yanming; Vasquez, Hernan G; Shen, Ying H; LeMaire, Scott A; Raffort, Juliette; Mallat, Ziad; Lu, Hong S; Daugherty, Alan; Hobbs, Adrian J. (2025). Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.. Arteriosclerosis, thrombosis, and vascular biology, 45(7), 1044-1063. https://doi.org/10.1161/ATVBAHA.124.322350
MLA
Aubdool, Aisah A, et al. "Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm.." Arteriosclerosis, 2025. https://doi.org/10.1161/ATVBAHA.124.322350
RethinkPeptides
RethinkPeptides Research Database. "Endothelium- and Fibroblast-Derived C-Type Natriuretic Pepti..." RPEP-10013. Retrieved from https://rethinkpeptides.com/research/aubdool-2025-endothelium-and-fibroblastderived-ctype
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.